Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 591

    1.

    Development, progression, and regression of microalbuminuria in Japanese patients with type 2 diabetes under tight glycemic and blood pressure control: the Kashiwa study.

    Yamada T, Komatsu M, Komiya I, Miyahara Y, Shima Y, Matsuzaki M, Ishikawa Y, Mita R, Fujiwara M, Furusato N, Nishi K, Aizawa T.

    Diabetes Care. 2005 Nov;28(11):2733-8.PMID: 16249548 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Albuminuria and 24-h ambulatory blood pressure in normoalbuminuric and microalbuminuric NIDDM patients. A longitudinal study.

    Nielsen S, Schmitz A, Poulsen PL, Hansen KW, Mogensen CE.

    Diabetes Care. 1995 Nov;18(11):1434-41.PMID: 8722066 [PubMed - indexed for MEDLINE]Related articles

    3.

    Role of glycemic control and blood pressure in the development and progression of nephropathy in elderly Japanese NIDDM patients.

    Tanaka Y, Atsumi Y, Matsuoka K, Onuma T, Tohjima T, Kawamori R.

    Diabetes Care. 1998 Jan;21(1):116-20.PMID: 9538981 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators.

    Levin SR, Coburn JW, Abraira C, Henderson WG, Colwell JA, Emanuele NV, Nuttall FQ, Sawin CT, Comstock JP, Silbert CK.

    Diabetes Care. 2000 Oct;23(10):1478-85.PMID: 11023140 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Systematic review on urine albumin testing for early detection of diabetic complications.

    Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

    Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.PMID: 16095545 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    The impact of metabolic and blood pressure control on incidence and progression of nephropathy. A 10-year study of 385 type 2 diabetic patients.

    Torffvit O, Agardh CD.

    J Diabetes Complications. 2001 Nov-Dec;15(6):307-13.PMID: 11711324 [PubMed - indexed for MEDLINE]Related articles

    8.

    Long-term lisinopril therapy reduces exercise-induced albuminuria in normoalbuminuric normotensive IDDM patients.

    Tuominen JA, Ebeling P, Koivisto VA.

    Diabetes Care. 1998 Aug;21(8):1345-8.PMID: 9702445 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    [Urinary albumin excretion by patients with type 2 diabetes mellitus. Effect of blood pressure and metabolic regulation]

    Jungmann E, Carlberg C, Schallmayer M, Schumm-Draeger PM.

    Med Klin (Munich). 1995 Jul 15;90(7):383-9. German. PMID: 7675002 [PubMed - indexed for MEDLINE]Related articles

    10.

    The relationship between early diabetic nephropathy and control of plasma glucose in non-insulin-dependent diabetes mellitus. The effect of glycemic control on the development and progression of diabetic nephropathy in an 8-year follow-up study.

    Kawazu S, Tomono S, Shimizu M, Kato N, Ohno T, Ishii C, Murata K, Watanabe T, Negishi K, Suzuki M, et al.

    J Diabetes Complications. 1994 Jan-Mar;8(1):13-7.PMID: 8167381 [PubMed - indexed for MEDLINE]Related articles

    11.

    High blood pressure is a risk factor for the development of microalbuminuria in Japanese subjects with non-insulin-dependent diabetes mellitus.

    Haneda M, Kikkawa R, Togawa M, Koya D, Kajiwara N, Uzu T, Shigeta Y.

    J Diabetes Complications. 1992 Jul-Sep;6(3):181-5.PMID: 1472744 [PubMed - indexed for MEDLINE]Related articles

    13.

    Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS).

    Ansquer JC, Foucher C, Rattier S, Taskinen MR, Steiner G; DAIS Investigators.

    Am J Kidney Dis. 2005 Mar;45(3):485-93.PMID: 15754270 [PubMed - indexed for MEDLINE]Related articles

    14.

    Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes.

    Powrie JK, Watts GF, Ingham JN, Taub NA, Talmud PJ, Shaw KM.

    BMJ. 1994 Dec 17;309(6969):1608-12.PMID: 7819935 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia.

    Ravid M, Brosh D, Ravid-Safran D, Levy Z, Rachmani R.

    Arch Intern Med. 1998 May 11;158(9):998-1004.PMID: 9588433 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Rate of progression of albuminuria in type II diabetes. Five-year prospective study from south India.

    John L, Rao PS, Kanagasabapathy AS.

    Diabetes Care. 1994 Aug;17(8):888-90.PMID: 7956637 [PubMed - indexed for MEDLINE]Related articles

    17.

    Prevalence and risk factors of microalbuminuria in a cohort of African-American women with gestational diabetes.

    Go RC, Desmond R, Roseman JM, Bell DS, Vanichanan C, Acton RT.

    Diabetes Care. 2001 Oct;24(10):1764-9.PMID: 11574439 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Increased urinary transferrin excretion predicts microalbuminuria in patients with type 2 diabetes.

    Kazumi T, Hozumi T, Ishida Y, Ikeda Y, Kishi K, Hayakawa M, Yoshino G.

    Diabetes Care. 1999 Jul;22(7):1176-80.PMID: 10388985 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Long-term impact of systolic blood pressure and glycemia on the development of microalbuminuria in essential hypertension.

    Pascual JM, Rodilla E, Gonzalez C, Pérez-Hoyos S, Redon J.

    Hypertension. 2005 Jun;45(6):1125-30. Epub 2005 May 16.PMID: 15897369 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Determinants of progression of microalbuminuria in patients with NIDDM.A prospective study.

    Smulders YM, Rakic M, Stehouwer CD, Weijers RN, Slaats EH, Silberbusch J.

    Diabetes Care. 1997 Jun;20(6):999-1005.PMID: 9167114 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data